Phase I study of oral eravacycline

Trial Profile

Phase I study of oral eravacycline

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Eravacycline (Primary)
  • Indications Gram-negative infections; Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jul 2017 According to a Tetraphase Pharmaceuticals media release top-line findings expected during the third quarter of 2017.
    • 06 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top